Latest Health News
US Signs $50 Billion Foreign Affairs Spending Bill, Averting Health Aid Cuts
The US Congress passed and the President signed a $50 billion foreign affairs spending bill on February 6, 2026, restoring billions in foreign assistance, NIH biomedical research, and domestic HIV programs after averting a shutdown and proposed deep cuts. The bill includes $5.9 billion for global HIV programs, with $4.6 billion via America First Global Health Strategy, $1.3 billion for Global Fund, and $45 million to UNAIDS, hailed by UNAIDS for sustaining life-saving support.
Despite reductions from prior years, implementation uncertainties persist.
WHO Launches $1 Billion Global Health Appeal for 36 Emergencies
WHO launched its 2026 Global Health Appeal seeking nearly $1 billion to sustain services for millions affected by conflicts, climate shocks, and outbreaks in 36 crises, including Grade 3 emergencies in Afghanistan, DRC, Sudan, and others. The appeal covers cholera, mpox, and disrupted health systems, reaching 30 million last year despite funding constraints.
Dr. Rabindra Abeyasinghe emphasized contributions as a moral imperative amid tight global funding.
WHO Faces Deepening Financial Crisis and US Withdrawal Fallout
UN and WHO risk financial collapse due to unpaid dues, US withdrawal, and declining funds; WHO's biggest financial drop in a decade prompts emergency appeal. China criticized US exit at WHO Executive Board, urging major countries to lead and bar easy withdrawals; Argentina also announced pullout.
Israel warned of pressure to withdraw post-US move.
Eastern Mediterranean Tops Global Humanitarian Health Needs with $633M Appeal
WHO requires $633 million plus $56 million for emergencies in Eastern Mediterranean, facing world's heaviest burden from conflicts, displacement, cholera, measles in Gaza, Sudan, Afghanistan, Pakistan. Nearly 115 million peopleāhalf global totalāneed aid amid weakened systems and attacks on healthcare.
WHO Regional Director Hanan Balkhy urged investment in health action and preparedness.
Johnson & Johnson Reports 90% Success in OMNY-AF Pilot for Atrial Fibrillation
OMNY-AF pilot study at 2026 AF Symposium showed 90% 12-month freedom from AFib, 100% acute success, zero procedure-related adverse events in 30 patients using OMNYPULSE catheter and TRUPULSE generator. 87.9% same-day discharge, 56.7% zero fluoroscopy; REAL AF registry confirmed low 0.5% safety events.
Data presented by Dinesh Sharma, M.D., highlights promising safety for pulsed field ablation.
Targeted Alpha-Radiation Plus Immunotherapy Slows Aggressive Lymphoma in Mice
Preclinical study paired alpha-radiation therapy with immune checkpoint drugs, slowing cancer growth, overcoming resistance, improving survival in mice with aggressive lymphoma tumors. Tested tumors with/without common targets, outperforming single treatments.
Published ahead-of-print in Journal of Nuclear Medicine.
New Theranostic Pair Advances Neuroendocrine Tumor Imaging and Therapy
Early-phase study evaluated SPECT/CT radiopharmaceutical for neuroendocrine tumors, assessing detection, optimal imaging timing, radiation dosimetry for personalized alpha-particle therapy. Matched imaging-therapy approach guides treatment planning.
Journal of Nuclear Medicine ahead-of-print.
New York City Joins WHO Global Outbreak Network Post-US Withdrawal
New York City Health Department joined WHO's GOARN in response to US withdrawal under Trump, defying federal move; Mayor Zohran Mamdani critical of policies. California and Illinois governors also pledged state participation.
Network aids global outbreak response.
Kisqali Gains Positive Recommendation for High-Risk Early Breast Cancer in Canada
Novartis' Kisqali (ribociclib) received positive draft recommendation from Canada's drug agency for all eligible HR+/HER2- early breast cancer patients at high recurrence risk. Builds on prior Health Canada approval.
Accessed February 2026.
UC Davis Cancer Center Unveils Radixact Linear Accelerator for Advanced Radiation
Cancer center leads region with new Radixact linear accelerator, enhancing precision radiation therapy to improve outcomes for patients. Unveiled February 2026.
Boosts treatment efficacy.
Study: Widespread Screening for Rare Cholesterol Disorder Not Cost-Effective
Northwestern study finds screening all young people for genetic high cholesterol (familial hypercholesterolemia) prevents heart issues but lacks cost-effectiveness. Published February 6, 2026.
Balances benefits against broad implementation costs.
Global Health Burdens from Plastics Could Double by 2040 Without Action
Health harms linked to plastic systems projected to double by 2040 absent immediate coordinated interventions. Highlights growing pollution-related risks.
Urgent call for global response.